XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Additional paid-in capital
Treasury stock
Accumulated deficit
Non-controlling interest
Redeemable Series C Preferred Stock
Preferred Stock
Class A
Common Stock
Class B
Common Stock
Beginning Balance (in shares) at Dec. 31, 2018           2,800 3,703 220
Beginning Balance at Dec. 31, 2018 $ 5,817 $ 181,632 $ (2,662) $ (196,091) $ 15,706 $ 7,193 $ 37 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             41  
Stock compensation and issuances 61 61            
Accrued liability settled through issuance of stock (in shares)             15  
Accrued liability settled through issuance of stock 35 35            
Shares withheld related to net share settlement of restricted stock awards (in shares)             (10)  
Net (loss) income 385     85 300      
Ending Balance (in shares) at Mar. 31, 2019           2,800 3,749 220
Ending Balance at Mar. 31, 2019 6,298 181,728 (2,662) (196,006) 16,006 $ 7,193 $ 37 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             30  
Stock compensation and issuances 187 186         $ 1  
Accrued liability settled through issuance of stock (in shares)             14  
Accrued liability settled through issuance of stock 36 36            
Shares withheld related to net share settlement of restricted stock awards (in shares)             (2)  
Warrant exercises (in shares)             200  
Warrant exercises 360 358         $ 2  
Class A stock conversion of non-controlling interest (in shares)             3,824  
Class A stock conversion of non-controlling interest 69 16,050     (16,019)   $ 38  
Series C conversion of non-controlling interest (in shares)           641    
Series C conversion of non-controlling interest (428)         $ (428)    
Net (loss) income (224)     (237) 13      
Ending Balance (in shares) at Jun. 30, 2019           3,441 7,815 220
Ending Balance at Jun. 30, 2019 6,298 198,358 (2,662) (196,243) 0 $ 6,765 $ 78 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             0  
Stock compensation and issuances 134 134            
Accrued liability settled through issuance of stock (in shares)             17  
Accrued liability settled through issuance of stock 35 35            
Gain on deconsolidation of discontinued operations 682 682            
Net (loss) income (627)     (627) 0      
Ending Balance (in shares) at Sep. 30, 2019           3,441 7,832 220
Ending Balance at Sep. 30, 2019 6,522 199,209 (2,662) (196,870) $ 0 $ 6,765 $ 78 $ 2
Beginning Balance (in shares) at Dec. 31, 2019           3,441 7,850 220
Beginning Balance at Dec. 31, 2019 8,357 199,372 (2,662) (195,198)   $ 6,765 $ 78 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             52  
Stock compensation and issuances 213 212         $ 1  
Accrued liability settled through issuance of stock (in shares)             11  
Accrued liability settled through issuance of stock 20 20            
Shares withheld related to net share settlement of restricted stock awards (in shares)             (16)  
Shares withheld related to net share settlement of restricted stock awards (31) (31)            
Net (loss) income (12)     (12)        
Ending Balance (in shares) at Mar. 31, 2020           3,441 7,897 220
Ending Balance at Mar. 31, 2020 8,547 199,573 (2,662) (195,210)   $ 6,765 $ 79 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             52  
Stock compensation and issuances 204 204         $ 0  
Accrued liability settled through issuance of stock (in shares)             9  
Accrued liability settled through issuance of stock 20 20            
Shares withheld related to net share settlement of restricted stock awards (in shares)             (16)  
Shares withheld related to net share settlement of restricted stock awards (30) (30)            
Net (loss) income 1,180     1,180        
Ending Balance (in shares) at Jun. 30, 2020           3,441 7,942 220
Ending Balance at Jun. 30, 2020 9,921 199,767 (2,662) (194,030)   $ 6,765 $ 79 $ 2
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Stock compensation and issuances (in shares)             3  
Stock compensation and issuances 179 179         $ 0  
Accrued liability settled through issuance of stock (in shares)             5  
Accrued liability settled through issuance of stock 14 14            
Shares withheld related to net share settlement of restricted stock awards (in shares)             (1)  
Shares withheld related to net share settlement of restricted stock awards (7) (7)            
Net (loss) income 423     423        
Ending Balance (in shares) at Sep. 30, 2020           3,441 7,949 220
Ending Balance at Sep. 30, 2020 $ 10,530 $ 199,953 $ (2,662) $ (193,607)   $ 6,765 $ 79 $ 2